In addition, miR-143 is also chemosensitizer to docetaxel in prostate cancer by targeting KRAS and subsequently targeting EGFR/RAS/MAPK pathway [27], while miR-145 inhibits EGFR mutant lung cancer cell growth, sensitizing to gifitinib [25]. The gene discussed is EGFR; the disease is lung cancer.